Epsilon Healthcare Limited announced the appointment of Mr. Josh Cui as a director of the Company effective, October 28, 2022. Xiao (Josh) Cui is the founder and CEO of Watercrest Capital Pty. Limited, a leading global private investment firm that manages alternative investments in multiple asset classes, including private equity, energy resources, hedge funds and other alternative investments.

Josh is a substantial shareholder in Epsilon. He holds a current RG 146 Forex certificate as well as The Securities Qualification Certificate from SAC. For the past 10 years, as a professional investor with an entrepreneurial vision, he generated attractive and most satisfactory investment returns by following flexible investment strategies to diversify across asset classes utilizing alternative hedging techniques, pursuing excellent performance, and aligning interests with his investment partners.

Since 2014, he co-founded and became the Managing Director of West Garden International Pty. Limited a sophisticated Property Investment Fund, specializing in Residential Real Estate Development Projects. He raised capital for the Property Investment Fund through connections from the HNV and institutional investors in Hongkong and mainland China.

He has in various capacities been involved in primary and secondary market investment through Private Equity funds, hedge funds and other entities, for IPOs of a number of companies in the Asia- Pacific region in the energy and resources, pharmaceutical, technology, real estate, logistics, culture and related sectors.